Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1985-09-09
1989-12-19
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 92, 4352523, 4352528, C12N 120, C12N 142, A61K 39112, A61K 3909
Patent
active
048881708
ABSTRACT:
This invention relates to a vaccine for the immunization of a vertebrate, comprising:
REFERENCES:
patent: 3879545 (1975-04-01), Gaffar et al.
patent: 3931398 (1976-01-01), Gaffar et al.
patent: 3993747 (1976-11-01), Gaffar et al.
patent: 4133875 (1979-01-01), Hillman
patent: 4150116 (1979-04-01), Taubman et al.
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4239749 (1980-12-01), Buchanan
patent: 4250262 (1981-02-01), Taubman et al.
patent: 4311797 (1982-01-01), Khachatourians
patent: 4448768 (1984-05-01), Colman et al.
patent: 4632830 (1980-12-01), Formal et al.
Proc. Natl. Acad. Sci. USA 78:5376-5380, 1981, A. R. Davis, et al., Expression of Antigenic Determinants of the Hemagglutinin Gene of a Human Influenza Virus in Escherichia coli.
Infection and Immunity 24:90-93, 1979. B. Diena et al., Mouse Protective Capabilities of Escherichia coli Hybrids Expressing Salmonella typhi Antigens.
Nature 291:503-506, 1981. J. X. Edman et al., Synthesis of Hepatitis B Surface and Core Antigens in E. coli.
Nature 292:851-852, 1981. I. Heiland et al., Cloned Copy of the Haemagglutinin Gene Codes for Human Influenza Antigenic Determinants in E. Coli.
Nature 279: 43-47, 1979. C. J. Burrell et al., Expression in Escherichia coli of Hepatitis B Virus DNA Sequences Cloned in Plasmid pBR322.
Dev. Genetics (Amsterdam). 1:113-122, 1979. W. S. Dallas et al., The Characterization of an Escherichia coli Plasmid Determinant that Encodes for the Production of Heat-Labile Enterotoxin.
Nucl. Acids Res. 6:849-865, 1979. D. E. Moon et al., Cloning, Mapping and Expression of the Genetic Determinant that Encodes for the K88ab Antigen.
Hazel Blondel
Research Corporation
LandOfFree
Vaccines obtained from antigenic gene products of recombinant ge does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines obtained from antigenic gene products of recombinant ge, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines obtained from antigenic gene products of recombinant ge will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1901684